NYSE American · Medical Devices · USD

Phaos Technology Holdings (Caym (POAS) Stock Analysis

Phaos Technology Holdings (Caym (POAS) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

POAS

$0.17

−$0.00 (−1.20%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare POAS with… →

POAS Key Statistics

As of Sep 4, 2026

Trading

Open: $0.17
Previous Close: $0.17
Day's Range: 0.16–0.17
52-Week Range: 0.15–7.40
Volume: 857.60K

Valuation

Market Cap: $5.20M
P/E Ratio: unprofitable
P/S ratio: 39.35
EPS (ttm): −0.38

Financials (FY)

Revenue (FY): $167.71K−91.09%
Net Income (FY): −$5.14M
Profit margin: 0.00%
Shares Outstanding: 16.45M

Dividend and dates

Avg Volume: 334.63K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

POAS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	−95.19%
2025 (partial year)	−10.91%

As of September 4, 2026.

POAS Revenue and Earnings by Fiscal Year

FY ends April

RevenueNet income

202220232024

Fiscal year	Revenue	Net income	Net margin
2024	$167.71K	−$5.14M	−3063.1%
2023	$1.88M	−$2.36M	−125.3%
2022	$650.80K	−$1.67M	−256.3%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2024	$167.71K	$37.07K	−$3.99M	−$5.14M	−3063.1%
2023	$1.88M	$811.17K	−$2.39M	−$2.36M	−125.3%
2022	$650.80K	$114.63K	−$1.68M	−$1.67M	−256.3%

Annual figures as reported, in the company's reporting currency. As of April 30, 2025.

POAS Valuation vs Medical Devices Median

Median of 151 stocks

Metric	POAS	Medical Devices median	vs median
P/S ratio	39.35	2.98	13.2x the median
Profit margin	0.00%	−1.69%	1.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

Phaos Technology Holdings (Caym (POAS) carries a market capitalisation of $5.20M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 10 employees.

Over the past 52 weeks the price has ranged from $0.15 to $7.40. The most recent close on file for POAS is $0.17, dated September 4, 2026. That is $0.00 (−1.20%) against the previous close. The latest close sits 12.24% above that 52-week low.

Financial Health

In fiscal 2024, Phaos Technology Holdings (Caym reported revenue of $167.71K. That is −91.09% against the prior fiscal year, when revenue was $1.88M. The same year closed with a net loss of $5.14M. The reported profit margin is 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are −0.38.

Across the 3 fiscal years on file, revenue moves from $650.80K in 2022 to $167.71K in 2024. Of those 3 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 39.35 times revenue. On price-to-sales that is 13.2 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The stored price history starts on November 13, 2025, and the total return since then is −95.71%.

Growth & Income

No dividend is on file for POAS.

So far in 2026 the price is −95.19%.

Peer Comparison

Phaos Technology Holdings (Caym (POAS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Phaos Technology Holdings (Caym	POAS	$5.20M	—
Abbott Laboratories	ABT	$187.45B	35.1
Medtronic plc.	MDT	$120.46B	22.9
Stryker Corporation	SYK	$116.27B	31.9

The Medical Devices industry average P/E ratio is 26.8x. Phaos Technology Holdings (Caym has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

MDT

Medtronic plc.

$120.46B

SYK

Stryker Corporation

$116.27B

BSX

Boston Scientific Corporation

$69.27B

Edwards Lifesciences Corporation

$51.82B

DXCM

DexCom, Inc.

$33.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

JNJ

Johnson & Johnson

$663.28B

ABBV

AbbVie Inc.

$453.19B

MRK

Merck & Co., Inc.

$370.89B

UNH

UnitedHealth Group Incorporated

$356.47B

View all Healthcare stocks →

About Phaos Technology Holdings (Caym

Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.

Visit website →